Globeflex Capital »

Castle Biosciences shares owned by Globeflex Capital

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Globeflex Capital from 13F filings

Historical chart of Globeflex Capital investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Globeflex Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Globeflex Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $146k 3.8k 38.90

More positions owned by Globeflex Capital

Intercorp Financial Services (IFS)
Exelixis (EXEL)
Copa Holdings Sa-class A (CPA)
Universal Health Services (UHS)
Tenet Healthcare Corporation (THC)
NCR Atleos Corp (NATL)
Rigel Pharmaceuticals (RIGL)
Blue Bird Corp (BLBD)
Cirrus Logic (CRUS)
EnerSys (ENS)
Allegheny Technologies Incorporated (ATI)
Marex Group (MRX)
Phibro Animal Health Corporati*on Cmn Class A (PAHC)
Ypf Sa (YPF)
Ibex (IBEX)

View all positions for Globeflex Capital

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Rtw Investments
Principal Financial Group
Portolan Capital Management
Dimensional Fund Advisors
Summit Partners Public Asset Management
State Street Corporation
Geode Capital Management
Palisade Capital Management
AIGH Capital Management
Allianz Asset Management
Millennium Management
Daniel D. Thurber
Nuveen

View all funds holding Castle Biosciences